捷迈邦美

最新新闻

• 评级变动
  RBC Capital Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Maintains Target Price $101
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
  TipRanks · 2026/8/13
• 评级变动
  Analysts Conflicted on These Healthcare Names: ArriVent BioPharma, Inc. (AVBP), Zimmer Biomet Holdings (ZBH) and Tecan Group AG (OtherTCHBF)
  TipRanks · 2026/8/14
• 评级变动
  BofA Securities Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $110
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  A Quick Look at Today's Ratings for Zimmer Biomet Holdings(ZBH.US), With a Forecast Between $99 to $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  CCORF Upgrades Zimmer Biomet Holdings(ZBH.US) to Buy Rating, Raises Target Price to $100
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• Barclays Initiates Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Announces Target Price $100
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 公司公告
  Zimmer Biomet Holdings: Zimmer Biomet Holdings, Inc. - Distribution Option Symbol: ZBH New Symbol: ZBH1 * * * Update * * *
  OCC · 2022/2/23
• BofA Securities Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 评级变动
  Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $93
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $99
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  BTIG Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/25
• RBC Capital Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 评级变动
  Evercore Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Cuts Target Price to $110
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• 评级变动
  Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• 评级变动
  UBS Upgrades Zimmer Biomet Holdings(ZBH.US) to Buy Rating, Raises Target Price to $115
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  J.P. Morgan Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $117
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Announces Target Price $106
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 公司公告
  Zimmer Biomet Holdings: Zimmer Biomet Holdings, Inc. - Distribution Option Symbol: ZBH New Symbol: ZBH1
  OCC · 2022/2/11
• 评级变动
  Truist Financial Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $106
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  TD Cowen Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Maintains Target Price $109
  \u5e02\u573a\u8d44\u8baf · 2026/6/26
• 评级变动
  Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $99
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL) and Zimmer Biomet Holdings (ZBH)
  TipRanks · 2026/7/1

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。